Medicover AB (publ)

OM:MCOV B 株式レポート

時価総額:SEK 28.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Medicover 過去の業績

過去 基準チェック /36

Medicoverの収益は年間平均-3.6%の割合で減少していますが、 Healthcare業界の収益は年間 増加しています。収益は年間29.5% 18%割合で 増加しています。 Medicoverの自己資本利益率は4%であり、純利益率は1.2%です。

主要情報

-3.6%

収益成長率

-5.0%

EPS成長率

Healthcare 業界の成長8.1%
収益成長率18.0%
株主資本利益率4.0%
ネット・マージン1.2%
次回の業績アップデート30 Oct 2024

最近の業績更新

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Recent updates

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting

Apr 20
With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting

Medicover (STO:MCOV B) Could Easily Take On More Debt

Apr 08
Medicover (STO:MCOV B) Could Easily Take On More Debt

収支内訳

Medicover の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

OM:MCOV B 収益、費用、利益 ( )EUR Millions
日付収益収益G+A経費研究開発費
30 Jun 241,911233160
31 Mar 241,826223040
31 Dec 231,746182970
30 Sep 231,68282970
30 Jun 231,61052940
31 Mar 231,54812800
31 Dec 221,510122710
30 Sep 221,489372700
30 Jun 221,455592530
31 Mar 221,442882480
31 Dec 211,3771022320
30 Sep 211,299932120
30 Jun 211,226902050
31 Mar 211,076521980
31 Dec 20998261960
30 Sep 20930141930
30 Jun 2087941830
31 Mar 20884161710
31 Dec 19844231580
30 Sep 19796191510
30 Jun 19751191440
31 Mar 19709201370
31 Dec 18672221290
30 Sep 18643281240
30 Jun 18620261200
31 Mar 18600231170
31 Dec 17580191130
30 Sep 17560101100
30 Jun 1754091060
31 Mar 1752261040
31 Dec 164974990
31 Dec 154168790
31 Dec 143654710

質の高い収益: MCOV Bには€6.9M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が31st March, 2024に影響を及ぼしています。

利益率の向上: MCOV Bの現在の純利益率 (1.2%)は、昨年(0.09%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: MCOV Bの収益は過去 5 年間で年間3.6%減少しました。

成長の加速: MCOV Bの過去 1 年間の収益成長率 ( 1492.9% ) は、5 年間の平均 ( 年間0.5%を上回っています。

収益対業界: MCOV Bの過去 1 年間の収益成長率 ( 1492.9% ) はHealthcare業界-8.4%を上回りました。


株主資本利益率

高いROE: MCOV Bの 自己資本利益率 ( 4.2% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘